| Dr Victor Catania, MD | |
|
100 Community Dr, Suite 102, Tobyhanna, PA 18466-8985 | |
| (570) 895-2300 | |
| (570) 895-4270 |
| Full Name | Dr Victor Catania |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 100 Community Dr, Tobyhanna, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457602328 | NPI | - | NPPES |
| 428505PZP | Other | PA | MEDICARE PTAN |
| 1030463000001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD455099 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital - Pocono | East stroudsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
| Family Care Centers Inc | 5395649347 | 197 |
News Archive
Worthington announced today the introduction of several new grades of Collagenase, recombinant Nucleases DNase I and RNases A, T1 & T2 and Neutral Protease (Dispase). All certified Animal/Xeno-Free (AF) to minimize potential BSE/TSE (prion) and mammalian virus contamination risks associated with bovine and other animal-sourced enzymes for primary and stem cell isolation, bioprocessing and other biopharm related applications.
Cancer cases in India have doubled in recent years. According to reports, India's cancer incidence was estimated at 1.15 million new patients in 2018 and is predicted to almost double by 2040.
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
The American Medical Group Association (AMGA) today delivered its initial comments regarding the much anticipated decision from the Supreme Court of the United States on the Patient Protection & Affordable Care Act (ACA).
› Verified 4 days ago
| Entity Name | Family Care Centers Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669563037 PECOS PAC ID: 5395649347 Enrollment ID: O20031121000497 |
News Archive
Worthington announced today the introduction of several new grades of Collagenase, recombinant Nucleases DNase I and RNases A, T1 & T2 and Neutral Protease (Dispase). All certified Animal/Xeno-Free (AF) to minimize potential BSE/TSE (prion) and mammalian virus contamination risks associated with bovine and other animal-sourced enzymes for primary and stem cell isolation, bioprocessing and other biopharm related applications.
Cancer cases in India have doubled in recent years. According to reports, India's cancer incidence was estimated at 1.15 million new patients in 2018 and is predicted to almost double by 2040.
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
The American Medical Group Association (AMGA) today delivered its initial comments regarding the much anticipated decision from the Supreme Court of the United States on the Patient Protection & Affordable Care Act (ACA).
› Verified 4 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Worthington announced today the introduction of several new grades of Collagenase, recombinant Nucleases DNase I and RNases A, T1 & T2 and Neutral Protease (Dispase). All certified Animal/Xeno-Free (AF) to minimize potential BSE/TSE (prion) and mammalian virus contamination risks associated with bovine and other animal-sourced enzymes for primary and stem cell isolation, bioprocessing and other biopharm related applications.
Cancer cases in India have doubled in recent years. According to reports, India's cancer incidence was estimated at 1.15 million new patients in 2018 and is predicted to almost double by 2040.
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
The American Medical Group Association (AMGA) today delivered its initial comments regarding the much anticipated decision from the Supreme Court of the United States on the Patient Protection & Affordable Care Act (ACA).
› Verified 4 days ago
| Entity Name | Schuylkill Health System Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588603567 PECOS PAC ID: 0840285532 Enrollment ID: O20040420001197 |
News Archive
Worthington announced today the introduction of several new grades of Collagenase, recombinant Nucleases DNase I and RNases A, T1 & T2 and Neutral Protease (Dispase). All certified Animal/Xeno-Free (AF) to minimize potential BSE/TSE (prion) and mammalian virus contamination risks associated with bovine and other animal-sourced enzymes for primary and stem cell isolation, bioprocessing and other biopharm related applications.
Cancer cases in India have doubled in recent years. According to reports, India's cancer incidence was estimated at 1.15 million new patients in 2018 and is predicted to almost double by 2040.
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
The American Medical Group Association (AMGA) today delivered its initial comments regarding the much anticipated decision from the Supreme Court of the United States on the Patient Protection & Affordable Care Act (ACA).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Victor Catania, MD 206 E Brown St, East Stroudsburg, PA 18301-3006 Ph: (570) 895-2300 | Dr Victor Catania, MD 100 Community Dr, Suite 102, Tobyhanna, PA 18466-8985 Ph: (570) 895-2300 |
News Archive
Worthington announced today the introduction of several new grades of Collagenase, recombinant Nucleases DNase I and RNases A, T1 & T2 and Neutral Protease (Dispase). All certified Animal/Xeno-Free (AF) to minimize potential BSE/TSE (prion) and mammalian virus contamination risks associated with bovine and other animal-sourced enzymes for primary and stem cell isolation, bioprocessing and other biopharm related applications.
Cancer cases in India have doubled in recent years. According to reports, India's cancer incidence was estimated at 1.15 million new patients in 2018 and is predicted to almost double by 2040.
Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease.
The American Medical Group Association (AMGA) today delivered its initial comments regarding the much anticipated decision from the Supreme Court of the United States on the Patient Protection & Affordable Care Act (ACA).
› Verified 4 days ago
Leah Michelle Arlequin, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Community Dr, Tobyhanna, PA 18466 Phone: 570-895-2300 Fax: 570-895-4270 |